Testing effectiveness (Phase 2)Looking for participantsNCT07572396
What this trial is testing
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities
Who this might be right for
High-risk HPV (Any Strain)LSIL, Low Grade Squamous Intraepithelial LesionASC-US+3 more
Amplexd Therapeutics, Inc. 45